“Manufacturer access to ACO physicians will likely be governed by restricted access, as the ACO model implies that physicians will spend more time with each patient and less time with sales reps,” said the report, a white paper titled, “Accountable Care Organization Clinical Integration: What the new framework means for Drug and Medical Device Manufacturers and the Market.”
The report, which mostly dealt with drugmakers, also predicted ACOs may form partnerships with manufacturers, under which the companies would help educate ACO physicians about appropriate use of products and would help with patient compliance and education programs.
Obtain a copy of the white paper by providing your name, email and job title at this link.
Read a release from Alliance Life Sciences Consulting Group on the white paper.
Related Articles on Device Manufacturers:
Devicemakers Want Wider Payments for New Technology Add-On
Medical Device Lobby Calls for 6 Changes in Federal Policy
MDMA Applauds Bills to Repeal Medical Device Tax
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
